A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT

Blood. 2017 Sep 7;130(10):1270-1273. doi: 10.1182/blood-2017-05-784306. Epub 2017 Jun 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Neoplasm / analysis*
  • Gene Deletion
  • Genes, MHC Class I*
  • Genes, MHC Class II*
  • Genetic Markers
  • HLA-A Antigens / analysis*
  • HLA-C Antigens / analysis*
  • HLA-DP beta-Chains / analysis*
  • Haplotypes
  • Health Services Needs and Demand
  • Hematopoietic Stem Cell Transplantation*
  • Histocompatibility
  • Humans
  • Leukemia / immunology
  • Leukemia / therapy
  • Neoplastic Stem Cells / immunology
  • Polymerase Chain Reaction / methods*
  • Recurrence
  • Tumor Escape

Substances

  • Antigens, Neoplasm
  • Genetic Markers
  • HLA-A Antigens
  • HLA-C Antigens
  • HLA-DP beta-Chains
  • HLA-DPB1 antigen